Predicting the need for blood transfusion requirement in postpartum hemorrhage.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 11 6 2021
medline: 24 11 2022
entrez: 10 6 2021
Statut: ppublish

Résumé

We aimed to assess the role of lactate and hemoglobin levels as predictors for the need for blood transfusion in post-partum hemorrhage (PPH). A retrospective cohort study of women with PPH in a single university-affiliated tertiary medical center between August 2018 and June 2020. PPH was defined as an estimated excessive blood loss (of more than 500 ml following vaginal delivery and 1000 ml following a cesarean delivery) requiring at least one uterotonic drug and fluid resuscitation. Women were stratified by the need of requiring blood transfusion due to hemorrhage. The criteria for blood transfusion were: (1) clinically severe uncontrollable ongoing hemorrhage; (2) symptomatic anemia (maternal tachycardia >110 beats per minute, dizziness, syncope or presyncope) in the presence of Hb 7-8 g/dL Overall, out of 22,241 deliveries during the study, 94 women were included, of them 26 (23.4%) required blood transfusion. The antepartum Hb level was lower in the transfused group (11.7 ± vs 12.4 ± 1.0 re/dL, The combination of SI, immediate postpartum Hb and lactate levels is a good predictor for the need of blood requirement in PPH.

Identifiants

pubmed: 34107848
doi: 10.1080/14767058.2021.1937992
doi:

Substances chimiques

Hemoglobins 0
Lactates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7911-7916

Auteurs

Emmanuel Attali (E)

Lis Hospital for Women, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ariel Many (A)

Lis Hospital for Women, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Guy Kern (G)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Lee Reicher (L)

Lis Hospital for Women, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Adiel Kahana (A)

Lis Hospital for Women, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Asaf Shemer (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Georgy Kagan (G)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Division of Anesthesiology, Pain and Critical Care, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Ronni Gamzu (R)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Yariv Yogev (Y)

Lis Hospital for Women, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Liat Zakar (L)

Lis Hospital for Women, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH